Liver X Receptor Agonist TO901317 Attenuates Paraquat-Induced Acute Lung Injury through Inhibition of NF-κB and JNK/p38 MAPK Signal Pathways

Liver X Receptor Agonist TO901317 Attenuates Paraquat-Induced Acute Lung Injury through Inhibition of NF-κB and JNK/p38 MAPK Signal Pathways

Paraquat (PQ) is a widely used herbicide with extremely high poisoning mortality mostly from acute lung injury (ALI) or progressive pulmonary fibrosis. Toxicity mechanisms remain unclear, but a redox cycling process that generates reactive oxygen species (ROS) is involved, as are inflammation and ce...

Full description

Bibliographic Details
Main Authors:	Xiao Hu, Haitao Shen, Yu Wang, Min Zhao
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/4652695

Similar Items

Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
by: Ying Dong, et al.
Published: (2015-01-01)

Protective effect of nerolidol on lipopolysaccharide-induced acute lung injury through the inhibition of NF-κB activation by the reduction of p38 MAPK and JNK phosphorylation
by: Shih-Pin Chen, et al.
Published: (2020-06-01)

Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling
by: Zhipeng Su, et al.
Published: (2021-03-01)

The Liver X Receptor Agonist TO901317 Ameliorates Behavioral Deficits in Two Mouse Models of Autism
by: Yulong Cai, et al.
Published: (2019-05-01)

Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats
by: Dorota Harasiuk, et al.
Published: (2016-06-01)

TLRs, NF-κB, JNK, and Liver Regeneration
by: Yuji Iimuro, et al.
Published: (2010-01-01)

Rubidium Chloride Targets Jnk/p38-Mediated NF-κB Activation to Attenuate Osteoclastogenesis and Facilitate Osteoblastogenesis
by: Zhengxiao Ouyang, et al.
Published: (2019-05-01)

JNK/P38 MAPK signaling pathway
by: Shuai Guan, et al.
Published: (2020-04-01)

Effect of a synthetic liver X receptor agonist TO901317 on cholesterol concentration in goose primary hepatocytes
by: Fang He, et al.
Published: (2014-03-01)

Humanin Attenuates NMDA-Induced Excitotoxicity by Inhibiting ROS-dependent JNK/p38 MAPK Pathway
by: Xiaorong Yang, et al.
Published: (2018-09-01)

Ginsenoside Compound K Attenuates Ox-LDL-Mediated Macrophage Inflammation and Foam Cell Formation via Autophagy Induction and Modulating NF-κB, p38, and JNK MAPK Signaling
by: Shan Lu, et al.
Published: (2020-09-01)

Camel Milk Mitigates Cyclosporine-Induced Renal Damage in Rats: Targeting p38/ERK/JNK MAPKs, NF-κB, and Matrix Metalloproteinases
by: Hany H. Arab, et al.
Published: (2021-05-01)

Luo Tong formula attenuates retinal inflammation in diabetic rats via inhibition of the p38MAPK/NF-κB pathway
by: Bing Pang, et al.
Published: (2020-01-01)

GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF-κB Pathways in LPS-Stimulated Microglial Cells
by: Gai-ying He, et al.
Published: (2014-01-01)

Paraquat-induced reactive oxygen species inhibit neutrophil apoptosis via a p38 MAPK/NF-κB-IL-6/TNF-α positive-feedback circuit.
by: Xiaolong Wang, et al.
Published: (2014-01-01)

Salusin-β, but not salusin-α, promotes human umbilical vein endothelial cell inflammation via the p38 MAPK/JNK-NF-κB pathway.
by: Cheng-Hua Zhou, et al.
Published: (2014-01-01)

Ipriflavone analogues inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38, JNK and NF-κB pathways
by: Ayaho Yamamoto, et al.
Published: (2010)

Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways
by: Chen Chien-Chih, et al.
Published: (2011-05-01)

A liver X receptors agonist, TO901317, improves long-term histological and functionl outcomes, attenuates brain edema, and reduces inflammation after intracerebral hemorrhage in mice
by: Lai, Jia-You, et al.
Published: (2011)

Hp-s1 Ganglioside Suppresses Proinflammatory Responses by Inhibiting MyD88-Dependent NF-κB and JNK/p38 MAPK Pathways in Lipopolysaccharide-Stimulated Microglial Cells
by: Jui-Hu Shih, et al.
Published: (2020-09-01)

The mechanism mediating the activation of acetyl-coenzyme A carboxylase-α gene transcription by the liver X receptor agonist T0-901317
by: Saswata Talukdar, et al.
Published: (2006-11-01)

Attenuation of TNF-α-Induced Inflammatory Injury in Endothelial Cells by Ginsenoside Rb1 via Inhibiting NF-κB, JNK and p38 Signaling Pathways
by: Ping Zhou, et al.
Published: (2017-08-01)

PRMT5 inhibition attenuates cartilage degradation by reducing MAPK and NF-κB signaling
by: Yonghui Dong, et al.
Published: (2020-09-01)

Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways
by: Xuantao Hu, et al.
Published: (2020-04-01)

Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways.
by: Byung-Wook Kim, et al.
Published: (2013-01-01)

Royal Jelly Attenuates LPS-Induced Inflammation in BV-2 Microglial Cells through Modulating NF-κB and p38/JNK Signaling Pathways
by: Meng-Meng You, et al.
Published: (2018-01-01)

Propofol attenuates intermittent hypoxia induced up-regulation of proinflammatory cytokines in microglia through inhibiting the activation of NF-Bκ/p38 MAPK signalling
by: Song Liu, et al.
Published: (2017-06-01)

Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-α gene transcription by the liver X receptor agonist T0-901317
by: Saswata Talukdar, et al.
Published: (2007-12-01)

Lipopolysaccharide-Binding Protein Downregulates Fractalkine through Activation of p38 MAPK and NF-κB
by: Xia Huang, et al.
Published: (2017-01-01)

Correction to: Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation
by: Xiangying Kong, et al.
Published: (2021-05-01)

Klotho Alleviates Lung Injury Caused by Paraquat via Suppressing ROS/P38 MAPK-Regulated Inflammatory Responses and Apoptosis
by: Zhiqiang Zhang, et al.
Published: (2020-01-01)

Fucosterol Protects against Concanavalin A-Induced Acute Liver Injury: Focus on P38 MAPK/NF-κB Pathway Activity
by: Wenhui Mo, et al.
Published: (2018-01-01)

Data on the phosphorylation of p38MAPK and JNK induced by chlorpyrifos in Drosophila melanogaster
by: J.E.S. Batista, et al.
Published: (2016-12-01)

Study on the Role of Paxillin Phosphorylated by JNK and p38 MAPK in T Cell Activation
by: Yu-Chi Lee, et al.

(+)-JQ1 attenuated LPS-induced microglial inflammation via MAPK/NFκB signaling
by: Huanhuan Wang, et al.
Published: (2018-11-01)

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
by: Shin Maeda
Published: (2010-01-01)

Pyrroloquinoline quinone (PQQ) inhibits lipopolysaccharide induced inflammation in part via downregulated NF-κB and p38/JNK activation in microglial and attenuates microglia activation in lipopolysaccharide treatment mice.
by: Chongfei Yang, et al.
Published: (2014-01-01)

A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation
by: Xin Liu, et al.
Published: (2016-03-01)

Fengshi Gutong Capsule Attenuates Osteoarthritis by Inhibiting MAPK, NF-κB, AP-1, and Akt Pathways
by: Yao-Xin Gao, et al.
Published: (2018-08-01)

Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease.
by: Irene Paterniti, et al.
Published: (2017-01-01)